A more accurate test for ovarian cancer is now available in the Quad Cities. But insurance companies won't pay for it yet. On Friday, the Norma Leah Foundation announced local women may request the ROCA blood test.
Nadia Altomare is the CEO of Abcodia, which is based in the United Kingdom with a branch in Boston. It developed the ROCA test over 30 years, concluding with a 15-year clinical trial with 200,000 women.